Nephrosclerosis
Showing 1 - 25 of 47
Hypertensive Nephrosclerosis, Chronic Renal Insufficiency Trial (MAP goal less than or equal to 92 mm Hg, MAP goal 102-107 mm
Completed
- Hypertensive Nephrosclerosis
- Chronic Renal Insufficiency
- MAP goal less than or equal to 92 mm Hg
- +4 more
- (no location specified)
Apr 23, 2020
Thrombin Generation Assay to Assess Thrombotic Risk in Nephrotic
Not yet recruiting
- Nephrotic Syndrome
-
Paris, FranceService de Néphrologie et Dialyses, Hôpital Tenon
Mar 21, 2022
Molecular Analysis of Diabetic Kidney Disease Biopsies
Recruiting
- Diabetic Nephropathies
- Kidney Disease, Chronic
- RNA sequencing
-
Vancouver, British Columbia, Canada
- +3 more
Apr 27, 2021
Myocardial Ischemia, Acute Coronary Syndrome Trial (Eptifibatide (Integrilin), Placebo)
Completed
- Myocardial Ischemia
- Acute Coronary Syndrome
- Eptifibatide (Integrilin)
- Placebo
- (no location specified)
Feb 7, 2022
Renal Ageing-sarcopenia Network
Unknown status
- Aging
- +3 more
-
Milan, ItalyIRCCS Ospedale San Raffaele
Dec 9, 2020
Bogalusa Heart Study
Active, not recruiting
- Atherosclerosis
- +4 more
-
New Orleans, LouisianaTulane University
Sep 12, 2022
Chronic Kidney Disease Trial in Worldwide (Dapagliflozin, Placebo)
Chronic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Completed
- Chronic Kidney Disease
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +977 more
Jun 29, 2021
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Placebo, Dapirolizumab pegol (DZP))
Completed
- Systemic Lupus Erythematosus (SLE)
- Placebo
- Dapirolizumab pegol (DZP)
-
Birmingham, Alabama
- +70 more
Jun 7, 2021
Rheumatoid Arthritis Trial in Worldwide (Adalimumab, Baricitinib, Methotrexate)
Hyperparathyroidism, Secondary Trial in Worldwide (Etelcalcetide)
Completed
- Hyperparathyroidism, Secondary
-
Birmingham, Alabama
- +208 more
Apr 1, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +445 more
Jul 10, 2019
Cardiovascular Diseases Trial in Worldwide (Evacetrapib, Placebo)
Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)
Atherosclerotic Cardiovascular Disease Trial in Worldwide (Alirocumab, Placebo, LMT)
Completed
- Atherosclerotic Cardiovascular Disease
- Alirocumab
- +2 more
-
Birmingham, Alabama
- +1387 more
Mar 15, 2019
Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban
Completed
- Stroke
- +2 more
- warfarin tablets
- +4 more
-
Birmingham, Alabama
- +1015 more
Feb 8, 2019
Type 2 Diabetes Trial in Worldwide (Exenatide Once Weekly, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Exenatide Once Weekly
- Placebo
-
Birmingham, Alabama
- +629 more
Jul 13, 2018
Metastatic Renal Cell Carcinoma (mRCC) Trial in Germany (Everolimus (RAD001))
Completed
- Metastatic Renal Cell Carcinoma (mRCC)
- Everolimus (RAD001)
-
Chemnitz, Germany
- +12 more
Jul 17, 2017
Methoxy Polyethylene Glycol-epoetin Beta in a Kidney Transplant
Completed
- Anemia, Kidney Transplantation
- Methoxy-polyethyleneglycol epoetin beta
-
Hann. Münden, GermanyKlinikum Hann. Münden, Nephrologisches Zentrum Niedersachsen
May 9, 2017
Chronic Renal Failure, Glomerular Disease, Nephrosclerosis Trial in Worldwide (TRK-100STP high dose, TRK-100STP low dose,
Completed
- Chronic Renal Failure
- +2 more
- TRK-100STP high dose
- +2 more
-
Beijing, China
- +6 more
Feb 3, 2015